Regeneron Pharmaceuticals Inc. buy piccolo90
Start price
21.12.17
/
50%
€348.58
Target price
06.03.18
€413.69
Performance (%)
-14.97%
End price
06.03.18
€296.39
Summary
This prediction ended on 06.03.18 with a price of €296.39. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.97%. piccolo90 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 4.330% | 4.330% | 35.944% | 122.003% |
| iShares Core DAX® | -2.926% | -4.228% | 9.878% | 12.466% |
| iShares Nasdaq 100 | 4.462% | 8.605% | 33.063% | 59.465% |
| iShares Nikkei 225® | 0.306% | 0.284% | 3.871% | 4.557% |
| iShares S&P 500 | 2.488% | 4.773% | 27.189% | 50.113% |
Comments by piccolo90 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 21.12.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 458.64$ zu.
(Vom Mitglied beendet)
Stopped prediction by piccolo90 for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€365.18
02.10.18
02.10.18
€412.21
10.07.19
10.07.19
-23.65%
10.07.19
10.07.19
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€276.91
13.05.18
13.05.18
€344.81
02.08.18
02.08.18
24.60%
02.08.18
02.08.18
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€345.60
04.04.17
04.04.17
€568.26
04.10.17
04.10.17
18.35%
04.10.17
04.10.17
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€342.21
03.05.16
03.05.16
€473.77
03.11.16
03.11.16
-9.42%
03.11.16
03.11.16
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€496.71
28.07.15
28.07.15
€505.12
04.08.15
04.08.15
8.56%
04.08.15
04.08.15